DNA "nano-claw": logic-based autonomous cancer targeting and therapy
- PMID: 24367989
- PMCID: PMC3935767
- DOI: 10.1021/ja4114903
DNA "nano-claw": logic-based autonomous cancer targeting and therapy
Abstract
Cell types, both healthy and diseased, can be classified by inventories of their cell-surface markers. Programmable analysis of multiple markers would enable clinicians to develop a comprehensive disease profile, leading to more accurate diagnosis and intervention. As a first step to accomplish this, we have designed a DNA-based device, called "Nano-Claw". Combining the special structure-switching properties of DNA aptamers with toehold-mediated strand displacement reactions, this claw is capable of performing autonomous logic-based analysis of multiple cancer cell-surface markers and, in response, producing a diagnostic signal and/or targeted photodynamic therapy. We anticipate that this design can be widely applied in facilitating basic biomedical research, accurate disease diagnosis, and effective therapy.
Figures
References
-
- Hollingsworth MA, Swanson BJ. Nat Rev Cancer. 2004;4:45. - PubMed
-
- Png KJ, Halberg N, Yoshida M, Tavazoie SF. Nature. 2012;481:190. - PubMed
-
- Ikeda A, Shankar DB, Watanabe M, Tamanoi F, Moore TB, Sakamoto KM. Mol Genet Metab. 2006;88:216. - PubMed
-
- Zhou H, Jiao P, Yang L, Li X, Yan B. J Am Chem Soc. 2011;133:680. - PubMed
-
- Kluza E, van der Schaft DW, Hautvast PA, Mulder WJ, Mayo KH, Griffioen AW, Strijkers GJ, Nicolay K. Nano Lett. 2010;10:52. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
